# BioMérieux acquires Astute Medical for $90 million

BioMérieux acquired Astute Medical, developer of the NephroCheck test, for approximately $90 million.

- Type: Acquisition
- Announced: 2018-04-24
- Where: United States
- Value: $90.0M
- Status: completed
- Products: NephroCheck test, diagnostic tests
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [bioMérieux](https://endata.com/companies/24346.md) (acquirer)
- [Astute Medical](https://endata.com/companies/31528.md) (target)

## Sources

- [captodayonline.com](https://www.captodayonline.com/biomerieux-buys-astute-medical/), 2018-04-24: "BioMérieux has acquired Astute Medical, developer of the NephroCheck test, for approximately $90 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.